PRJNA207719: Tissue specific transcriptome profiling
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
myod1 | dr11_v1_chr25_-_31423493_31423493 | 0.84 | 7.7e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr8_-_1051438 Show fit | 2.02 |
ENSDART00000067093
ENSDART00000170737 |
SET and MYND domain containing 1b |
|
chr22_-_14128716 Show fit | 1.81 |
ENSDART00000140323
|
si:ch211-246m6.4 |
|
chr3_-_32817274 Show fit | 1.63 |
ENSDART00000142582
|
myosin light chain, phosphorylatable, fast skeletal muscle a |
|
chr3_+_32526799 Show fit | 1.54 |
ENSDART00000185755
|
si:ch73-367p23.2 |
|
chr3_+_32526263 Show fit | 1.40 |
ENSDART00000150897
|
si:ch73-367p23.2 |
|
chr22_-_651719 Show fit | 1.37 |
ENSDART00000148692
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2a |
|
chr2_+_55982940 Show fit | 1.37 |
ENSDART00000097753
ENSDART00000097751 |
nicotinamide riboside kinase 2 |
|
chr6_-_42003780 Show fit | 1.30 |
ENSDART00000032527
|
caveolin 3 |
|
chr20_-_27325258 Show fit | 1.24 |
ENSDART00000152917
|
ankyrin repeat and SOCS box containing 2a, tandem duplicate 1 |
|
chr9_-_98982 Show fit | 1.22 |
ENSDART00000147882
|
LIM and senescent cell antigen-like domains 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 3.2 | GO:0003210 | cardiac atrium formation(GO:0003210) |
0.2 | 2.8 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.3 | 2.5 | GO:0003209 | cardiac atrium morphogenesis(GO:0003209) |
0.2 | 2.1 | GO:0061620 | glucose catabolic process(GO:0006007) NADH regeneration(GO:0006735) glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
0.7 | 2.0 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.0 | 1.7 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.0 | 1.7 | GO:0030239 | myofibril assembly(GO:0030239) |
0.5 | 1.4 | GO:0016554 | cytidine to uridine editing(GO:0016554) positive regulation of DNA binding(GO:0043388) |
0.1 | 1.4 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
0.1 | 1.4 | GO:0055008 | cardiac muscle tissue morphogenesis(GO:0055008) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 7.2 | GO:0030018 | Z disc(GO:0030018) |
0.2 | 5.5 | GO:0031672 | A band(GO:0031672) |
0.0 | 2.9 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.1 | 2.6 | GO:0005901 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
0.1 | 2.3 | GO:0005861 | troponin complex(GO:0005861) |
0.2 | 2.1 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 1.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 1.1 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 0.6 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.6 | GO:0061617 | MICOS complex(GO:0061617) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.8 | GO:0051015 | actin filament binding(GO:0051015) |
0.3 | 3.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.4 | 2.6 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) |
0.2 | 2.1 | GO:0070095 | 6-phosphofructokinase activity(GO:0003872) fructose-6-phosphate binding(GO:0070095) |
0.1 | 1.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 1.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.2 | 1.7 | GO:0051373 | telethonin binding(GO:0031433) FATZ binding(GO:0051373) |
0.1 | 1.7 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 1.6 | GO:0044325 | ion channel binding(GO:0044325) |
0.3 | 1.3 | GO:0071253 | connexin binding(GO:0071253) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.6 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 1.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 1.3 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 1.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 0.7 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.0 | 0.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.2 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.1 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.1 | 0.9 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 0.8 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 0.8 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 0.8 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 0.5 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 0.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.4 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |